Longevity Labs Wins the 2021 German Innovation Award for its dietary supplement, spermidineLIFE®

Longevity Labs Wins the 2021 German Innovation Award


MUNICH/VIENNA/DENVER, June 24, 2021 – Award recognizes a successful and innovative product advancing longevity research in humans

Longevity Labs Inc., an Austria and U.S.-based company focused on developing cutting edge compounds to increase human health and lifespan, today announced that it has earned a German Innovation Award from the German Design Council, a Germany-based non-profit organization, for its anti-aging dietary supplement spermidineLIFE®.

The German Innovation Awards recognize companies for creating successful and innovative products that will make a better future. The awards are given in 18 business categories and 22 business-to-consumer categories. Longevity Labs received the ‘Excellence in Business to Business – Pharmaceuticals’ category. The awards ceremony took place virtually on May 18, 2021and Longevity Labs, along with its German distribution partner, InfectoPharm, were both honored.

“Longevity Labs continues to be recognized for the efficacy of our spermidineLIFE® longevity supplement product across the E.U. by industry professionals, researchers, and consumers alike,” said Daniel Dietz, CEO of Longevity Labs USA. “While this is a new compound and product in the U.S., we expect that the clinical research and recognition that spermidineLIFE® has been part of in Europe will be of significant interest to longevity markets worldwide.”

spermidineLIFE® is backed by more than ten years of biomedical research and is the world’s first clinically tested and naturally extracted dietary supplement that promotes the renewal of cells through autophagy. The active ingredient in spermidineLIFE® is spermidine, an aliphatic polyamine compound found in ribosomes and living tissue and considered key to maintaining youthful cell function.

Previously in 2020, Longevity Labs received the Pharma Trend “Image & Innovation” award for spermidineLIFE® which was voted as Germany's most innovative OTC product by customers, pharmacists, and doctors.

After spermidineLIFE®’s European market launch in 2019, in 2020 Longevity Labs began sales of its product in the United States via eCommerce sales on its website, www.spermidinelife.us. In August 2020, spermidineLIFE® became the first commercially available, safety-tested, lab-verified, spermidine-rich supplement in the U.S. market. spermidineLIFE® is recognized globally as the original spermidine supplement.

For more information about spermidineLIFE® or to place an order directly through Longevity Labs, please visit www.spermidinelife.us.

  • Don Moxley - Director of Applied Science

    Don Moxley is the Director of Applied Science at Longevity Labs. Moxley draws upon his career as an athlete, a sports scientist, and an instructor to lead and educate on the science of autophagy and longevity.